BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 68 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $535,000 | +11.7% | 158,629 | -3.3% | 0.00% | 0.0% |
| Q4 2018 | $479,000 | +112.9% | 164,060 | +349.3% | 0.00% | – |
| Q3 2018 | $225,000 | -78.0% | 36,517 | -73.6% | 0.00% | -100.0% |
| Q2 2018 | $1,022,000 | +527.0% | 138,493 | +458.9% | 0.00% | – |
| Q1 2018 | $163,000 | -24.2% | 24,778 | -3.0% | 0.00% | – |
| Q4 2017 | $215,000 | -39.4% | 25,553 | -16.8% | 0.00% | -100.0% |
| Q3 2017 | $355,000 | -0.8% | 30,728 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $358,000 | +23.9% | 30,668 | +31.0% | 0.00% | 0.0% |
| Q1 2017 | $289,000 | -7.1% | 23,419 | +2.5% | 0.00% | 0.0% |
| Q4 2016 | $311,000 | -19.8% | 22,858 | +17.3% | 0.00% | 0.0% |
| Q3 2016 | $388,000 | +64.4% | 19,494 | +6.9% | 0.00% | 0.0% |
| Q2 2016 | $236,000 | – | 18,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |